Logo image
Use of graded Semmes Weinstein monofilament testing for ascertaining peripheral neuropathy in people with and without diabetes
Journal article   Peer reviewed

Use of graded Semmes Weinstein monofilament testing for ascertaining peripheral neuropathy in people with and without diabetes

Muideen T. Olaiya, Robert L. Hanson, Karen G. Kavena, Madhumita Sinha, Dawn Clary, Mark B. Horton, Robert G. Nelson and William C. Knowler
Diabetes research and clinical practice, Vol.151, pp.1-10
05/01/2019
PMID: 30922942

Abstract

Endocrinology & Metabolism Life Sciences & Biomedicine Science & Technology
Aims: To assess peripheral neuropathy (PN) using graded Semmes Weinstein monofilaments (SWMs) and determine factors associated with PN among adult volunteers with and without diabetes. Methods: Adult volunteers were assessed for distal sensory PN using three graded SWMs. Four PN levels were defined: 0 (no PN; felt all three filaments), 1 (subclinical PN; insensate to 1-g filament), 2 (insensate to 10-g), or 3 (insensate to 75-g). Levels 2-3 were considered clinical PN. Associations with PN were determined using ordinal logistic regression. Results: In 1564 subjects (median age 41.9 years, 50.1% women), PN was subclinical or worse in 68.9% and clinical in 11.2%. Age-sex-race-adjusted prevalence of clinical PN was greater in people with diabetes (15.3%) than without (6.1%; P < 0.001). Associated factors included older age, male sex, greater BMI, greater heart rate, lower mean arterial pressure, and family history of diabetes or cardiovascular diseases. Higher PN levels associated with worse albuminuria and retinopathy. Only older age and male sex associated with PN both in people with and without diabetes. Conclusions: PN is common in our sample, notably in those without diabetes, although diabetes greatly increases its risk. Using graded SWMs may have a prognostic value as it permits the identification of subclinical PN. Published by Elsevier B.V.

Metrics

1 Record Views

Details

Logo image